𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Prediction of response to chemotherapy by ERCC1 immunohistochemistry and ERCC1 polymorphism in ovarian cancer

✍ Scribed by K.D. STEFFENSEN; M. WALDSTRØM; U. JEPPESEN; I. BRANDSLUND; A. JAKOBSEN

Book ID
109086270
Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
469 KB
Volume
18
Category
Article
ISSN
1048-891X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

ERCC1 and XPD/ERCC2 Polymorphisms’ Predi
ERCC1 and XPD/ERCC2 Polymorphisms’ Predictive Value of Oxaliplatin-Based Chemotherapies in Advanced Colorectal Cancer has an Ethnic Discrepancy: A Meta-analysis
✍ Xiaobo Lu; Sha Xiao; Cuihong Jin; Tahar van der Straaten; Xiaoxia Li 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 464 KB

Our purpose is to evaluate the predictive value of the genetic polymorphisms of Excision repair cross-complementing group 1 (ERCC1) and xeroderma pigmentosum group D/excision repair crosscomplementing group 2 (XPD/ERCC2) in patients with advanced colorectal cancer receiving oxaliplatin-based chemoth

The DNA repair proteins BRCA1 and ERCC1
The DNA repair proteins BRCA1 and ERCC1 as predictive markers in sporadic ovarian cancer
✍ Johanne Weberpals; Kyla Garbuio; Anna O'Brien; Katherine Clark-Knowles; Steve Do 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 466 KB

## Abstract This study compares __Br__east __Ca__ncer 1 (__BRCA1__) and excision repair cross complementation group 1 (__ERCC1__) expression as predictive markers and evaluates the __in vitro__ enhancement of platinum sensitivity using targeted agents in sporadic ovarian cancer (OC). A retrospectiv